Comprehensive Study Notes on Vaccines: History, Types, and Public Health Impact

Vaccines

Introduction to Vaccines

Vaccines are biological preparations that provide acquired immunity to specific infectious diseases. Their development and use have led to major triumphs in public health, but have also been accompanied by controversies and challenges.

• Definition: A vaccine stimulates the immune system to recognize and combat pathogens, such as viruses or bacteria.

• Purpose: Prevent infectious diseases by inducing immunological memory.

History of Vaccination

Early Practices: Variolation

Hundreds of years ago, the Chinese practiced variolation to combat smallpox.

• Method: Powder made from dried scabs of smallpox was inhaled or inserted into the skin.

• Outcome: Resulting infections tended to be milder, with a 1–2% mortality rate, compared to natural smallpox.

Edward Jenner’s Smallpox Vaccination Experiment

Edward Jenner (1796) pioneered the first true vaccination using cowpox to protect against smallpox.

• Experiment: Jenner inoculated James Phipps with material from cowpox lesions.

• Term: The word vaccination is derived from vacca, Latin for cow.

• Impact: Smallpox vaccination was soon mandated for British soldiers and widely adopted.

Louis Pasteur and Further Vaccine Development

Louis Pasteur (late 1800s) expanded vaccine science.

• Rabies Vaccine: Developed an early version to protect humans.

• Anthrax Vaccine: Developed for cattle.

• Expansion: As knowledge of pathogens increased, more vaccines were developed. Currently, at least 25 different infections are vaccine-preventable.

Types of Vaccines Licensed for Use in the United States

Overview of Licensed Vaccines

Vaccines licensed in the United States vary by administration route, formulation, and targeted disease.

Vaccine	Administration	Formulation	Notes
Oral polio vaccine	Oral	Live attenuated	Protects against poliovirus
Rabies vaccine	Intramuscular injection	Purified subunit	Pre- and post-exposure prophylaxis
BCG (tuberculosis)	Intramuscular injection	Live attenuated	Not routine in US
Cholera vaccine	Oral	Live attenuated	Protects against Vibrio cholerae
DTaP (diphtheria, tetanus, pertussis)	Intramuscular injection	Subunit combination	Protects against diphtheria, tetanus, pertussis
Hib (Haemophilus influenzae type b)	Intramuscular injection	Conjugate	Protects against Haemophilus influenzae
Hepatitis B	Intramuscular injection	Recombinant subunit	Protects against hepatitis B virus
Influenza	Intramuscular injection	Whole-agent inactivated	Annual vaccination recommended
MMR (measles, mumps, rubella)	Subcutaneous injection	Live attenuated	Protects against measles, mumps, rubella

Additional info: Table entries inferred and summarized for clarity.

Eradication through Vaccination

Smallpox Eradication

Smallpox is no longer a disease civilians are vaccinated against because it was eradicated through global vaccination efforts.

• WHO Role: The World Health Organization (WHO) was instrumental in bringing vaccines to developing nations and eradicating smallpox.

• Next Target: Polio is the next disease targeted for eradication.

Vaccination Fears and the Re-Emergence of Health Threats

Controversies and Public Concerns

Concerns about vaccine safety re-emerged in 1998 after a study claimed a link between the MMR vaccine and autism.

• Study: Published in The Lancet, based on only 12 patients.

• Impact: Led to a decline in vaccination rates in the US and UK.

Scientific Evidence and Outbreaks

• Subsequent Studies: Large studies (e.g., 2015 study of 95,000 children) found no link between vaccines and autism.

• Outbreaks: Drop in childhood vaccination led to outbreaks of measles and pertussis. Example: 2015 measles outbreak at Disneyland resulted in 189 cases across 24 states.

Policy Responses

• School Enrollment: Some areas changed rules to require immunizations for school or daycare attendance, allowing only medical exemptions.

Immunity Acquisition and Vaccine Formulations

Methods of Immunization

Vaccines can be injected, inhaled, or ingested and are available in diverse formulations.

• Types: Weakened (attenuated) microbe, fragments (subunit), inactivated toxin (toxoid), genetically manufactured portions.

• Immunological Memory: Vaccines stimulate memory, but may take several weeks for full response; boosters may be required.

• Contraindications: Some vaccines are not recommended for pregnant women or immune-compromised patients.

• Herd Immunity: Vaccinating a sufficient percentage of the population protects nonvaccinated individuals.

Herd Immunity and Immunization Programs

Concept of Herd Immunity

Herd immunity occurs when a high percentage of a population is immune, making it difficult for a pathogen to spread.

• Thresholds: Most pathogens require ~85% vaccination for effective herd immunity; measles and whooping cough require ~95%.

Immunization Across the Lifespan

• Adolescents: Bacterial meningitis vaccine recommended for ages 16–23.

• Pregnant Women: Tdap recommended in the third trimester.

• Annual Vaccines: Everyone >6 months should get annual influenza vaccine.

• Seniors: Vaccines for bacterial pneumonia and shingles are recommended.

Types of Vaccines

Attenuated Vaccines

Contain altered pathogens that do not cause disease but are still infectious.

• Development: Cultivated in cell culture or genetically manipulated to lose pathogenicity.

• Benefits: Potent immunological responses and long-lived memory.

• Drawbacks: Risk of disease in immune-compromised individuals, possible mutation, must be refrigerated.

Inactivated Vaccines: Whole-Agent and Subunit

Consist of whole inactivated pathogens or subunits.

• Benefits: Safe for immune-compromised patients, stable at room temperature.

• Drawbacks: Boosters required for full immunity.

Subunit, Toxoid, and Conjugate Vaccines

• Subunit Vaccines: Require adjuvants (e.g., aluminum salts, monophosphoryl lipid A).

• Toxoid Vaccines: Examples include tetanus and diphtheria (DTaP, Tdap).

• Conjugate Vaccines: Examples include meningococcal, pneumococcal, and Hib vaccines.

New Vaccine Technologies

Recombinant Vector Vaccines

Genetic material from the pathogen is packed inside a harmless virus or bacterium and inserted into the body to induce immunity.

• Application: Used for persistent and emerging diseases.

Cellular and Humoral Immune Responses

Vaccines induce both cellular and humoral immune responses, providing comprehensive protection against pathogens.

• Cellular Response: Involves T cells targeting infected cells.

• Humoral Response: Involves B cells producing antibodies.

Additional info: Academic context added for completeness and clarity.